All Strengths of Digitek (Digoxin) Tablets Recalled
In April, the U.S. Food and Drug Administration (FDA) issued a recall of all strengths of the Digitek® brand of digoxin tablets. The tablets are being recalled because some of them may actually contain twice as much digoxin and appear larger in size (thicker) than normal. The existence of double-strength tablets poses a serious risk of digitalis toxicity. Signs and symptoms of toxicity may include nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia (abnormally slow heart rate).
Despite these risks, it is also dangerous to skip doses of digoxin. Unless your medication appears altered or of a different tablet thickness or shape, continue to take your medication until you can obtain a new supply.
Note: Only Digitek tablets are indicated in the recall. Digoxin capsules and Lanoxin® brand tablets are not involved in the recall. You may need to call your pharmacy in order to verify the manufacturer of your digoxin medication.
To find out more information about whether or not your medication has been recalled:
1. Gather all bottles of digoxin tablets.
2. Check to see if they are labeled with the words Digitek, Bertek or UDL laboratories (UDL) names on the product. You may need to contact your pharmacy to help you make this determination.
3. Call your pharmacy and ask how you can get a new supply of your medication.
If you have any questions related to the recall, call the manufacturer's hotline at 1-888-276-6166. For more information about the FDA's statement about this recall, visit www.fda.gov. As always, we encourage you to speak with your doctor if you have any questions about your medications.
Back to top